Zobrazeno 1 - 5
of 5
pro vyhledávání: '"C. Sjowall"'
Autor:
L. Van Hoovels, B. Vander Cruyssen, D. Sieghart, C. Bonroy, E. Nagy, R. Pullerits, S. Čučnik, C. Dahle, I. Heijnen, L. Bernasconi, F. Benkhadra, L. Bogaert, S. Van Den Bremt, A. Vanliedekerke, G. Vanheule, J. Robbrecht, L. Studholme, W. Claudine, R. Müller, D. Kyburz, C. Sjowall, A. Kastbom, R. Jese, B. Jovancevic, E. V. Kiss, P. Jacques, G. Steiner, P. Verschueren, X. Bossuyt
Publikováno v:
Annals of the Rheumatic Diseases. 81:530-531
BackgroundRheumatoid factor (RF) and anti-cyclic citrullinated protein/peptide antibodies (ACPA) are included in the ACR/EULAR 2010 classification criteria for rheumatoid arthritis (RA)(1). Both markers are given the same weight in the criteria.Objec
Autor:
E. Lönnblom, M. Leu Agelii, O. Sareila, I. Hafström, M. Andersson, L. Cheng, G. Bergström, A. K. H. Ekwall, A. Rudin, A. Kastbom, C. Sjowall, B. Xu, L. T. H. Jacobsson, J. Viljanen, J. Kihlberg, I. Gjertsson, R. Holmdahl
Publikováno v:
Annals of the Rheumatic Diseases. 81:546.1-546
BackgroundAutoantibodies to citrullinated protein (ACPA; measured as anti-CCP; aCCP) and rheumatoid factor (RF) appear years before clinical onset of RA and are essential tools in today’s classification criteria for RA. In animal models, antibodies
Publikováno v:
Annals of the Rheumatic Diseases. 81:1402.1-1402
BackgroundPatients with systemic lupus erythematosus (SLE) experience impaired health-related quality of life (HRQoL), pain, fatigue and functional disability. The effect of pharmacotherapy on these aspects has been inconclusive in literature. In lig
Autor:
Katerina Chatzidionysiou, Carl Turesson, Alf Kastbom, D. Di Giuseppe, Bénédicte Delcoigne, E. Lindqvist, Gerd-Marie Alenius, Johan Askling, Ulf Lindström, Nils Feltelius, Thomas Frisell, Eva Baecklund, L. Klareskog, Hannah Bower, Helena Forsblad-d'Elia, C. Sjowall
Publikováno v:
Annals of the Rheumatic Diseases. 80:864-865
Background:Studies from COVID-19 case-repositories among patients with rheumatic diseases have assessed associations (relative risks) between characteristics of the disease and adverse COVID-19 outcomes. Such designs are susceptible to bias from sele
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.